|
G |
Acaa1a |
acetyl-CoA acyltransferase 1A |
increases response to substance |
ISO |
ACAA1 protein results in increased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624
|
|
G |
Agr2 |
anterior gradient 2, protein disulphide isomerase family member |
increases response to substance |
ISO |
AGR2 protein results in increased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 6:52,708,602...52,729,378
Ensembl chr 6:52,708,602...52,729,371
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
decreases response to substance |
ISO |
AKR1B1 protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
increases response to substance |
ISO |
AKR1C3 protein results in increased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Anxa8 |
annexin A8 |
decreases response to substance |
ISO |
ANXA8 protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr16:9,397,144...9,412,072
Ensembl chr16:9,397,113...9,412,043
|
|
G |
Arl4d |
ARF like GTPase 4D |
decreases response to substance |
ISO |
ARL4D protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr10:86,592,054...86,602,843
Ensembl chr10:86,595,661...86,602,836
|
|
G |
Axl |
Axl receptor tyrosine kinase |
decreases response to substance |
ISO |
AXL protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 1:81,265,088...81,296,278
Ensembl chr 1:81,265,088...81,296,265
|
|
G |
Ccn1 |
cellular communication network factor 1 |
decreases response to substance |
ISO |
CCN1 protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Cib1 |
calcium and integrin binding 1 |
increases response to substance |
ISO |
CIB1 protein results in increased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 1:134,178,331...134,183,895
Ensembl chr 1:134,178,331...134,213,423
|
|
G |
Cldn3 |
claudin 3 |
increases response to substance |
ISO |
CLDN3 protein results in increased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr12:21,708,538...21,710,010
Ensembl chr12:21,708,398...21,711,001
|
|
G |
Dapk1 |
death associated protein kinase 1 |
increases response to substance |
ISO |
DAPK1 protein results in increased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
affects expression multiple interactions decreases response to substance affects response to substance |
ISO |
doxifluridine affects the expression of DPYD mRNA [Paclitaxel co-treated with doxifluridine] affects the expression of DPYD mRNA DPYD protein results in decreased susceptibility to doxifluridine DPYD protein affects the susceptibility to doxifluridine |
CTD |
PMID:16646564 PMID:16734730 PMID:18630517 |
|
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Dse |
dermatan sulfate epimerase |
decreases response to substance |
ISO |
DSE protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr20:26,118,194...26,196,889
Ensembl chr20:26,118,196...26,196,992
|
|
G |
Elf3 |
E74 like ETS transcription factor 3 |
increases response to substance |
ISO |
ELF3 protein results in increased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr13:46,690,460...46,695,394
Ensembl chr13:46,690,466...46,695,481
|
|
G |
Eps8 |
EGFR pathway substrate 8, signaling adaptor |
increases response to substance |
ISO |
EPS8 protein results in increased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 4:170,388,378...170,486,873
Ensembl chr 4:170,388,378...170,486,873
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
increases response to substance |
ISO |
ERBB3 protein results in increased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Etnk1 |
ethanolamine kinase 1 |
increases response to substance |
ISO |
ETNK1 protein results in increased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 4:176,126,056...176,170,325
Ensembl chr 4:176,126,180...176,193,770
|
|
G |
Fhl1 |
four and a half LIM domains 1 |
decreases response to substance |
ISO |
FHL1 protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr X:134,555,399...134,614,930
Ensembl chr X:134,555,479...134,614,928
|
|
G |
Flii |
FLII, actin remodeling protein |
decreases response to substance |
ISO |
FLII protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr10:45,394,032...45,408,051
Ensembl chr10:45,394,032...45,407,970
|
|
G |
Fuca1 |
alpha-L-fucosidase 1 |
increases response to substance |
ISO |
FUCA1 protein results in increased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 5:148,152,718...148,169,972
Ensembl chr 5:148,152,700...148,169,972
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
decreases response to substance |
ISO |
HIF1A protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
decreases response to substance |
ISO |
HRAS protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Ifna1 |
interferon, alpha 1 |
multiple interactions |
ISO |
[TYMP protein results in increased expression of IFNA1 mRNA] which results in increased susceptibility to doxifluridine |
CTD |
PMID:17988526 |
|
NCBI chr 5:103,097,356...103,097,925
Ensembl chr 5:103,097,356...103,097,925
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
[IFNG protein results in increased expression of TYMP protein] which results in increased susceptibility to doxifluridine |
CTD |
PMID:15301717 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il17rb |
interleukin 17 receptor B |
increases response to substance |
ISO |
IL17RB protein results in increased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr16:5,180,431...5,194,125
Ensembl chr16:5,180,432...5,194,125
|
|
G |
Il6 |
interleukin 6 |
increases expression increases secretion multiple interactions |
ISO |
doxifluridine results in increased expression of IL6 mRNA doxifluridine results in increased secretion of IL6 protein 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [doxifluridine results in increased expression of IL6 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [doxifluridine results in increased secretion of IL6 protein]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [doxifluridine results in increased expression of IL6 mRNA]; pyrazolanthrone inhibits the reaction [doxifluridine results in increased expression of IL6 mRNA]; SB 203580 inhibits the reaction [doxifluridine results in increased expression of IL6 mRNA]; SB 203580 inhibits the reaction [doxifluridine results in increased secretion of IL6 protein] |
CTD |
PMID:35147423 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Lgals4 |
galectin 4 |
increases response to substance |
ISO |
LGALS4 protein results in increased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 1:84,124,766...84,132,481
Ensembl chr 1:84,124,764...84,132,481
|
|
G |
Mre11 |
MRE11 homolog, double strand break repair nuclease |
decreases response to substance |
ISO |
MRE11 protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 8:11,618,876...11,680,451
Ensembl chr 8:11,632,354...11,678,279
|
|
G |
Myb |
MYB proto-oncogene, transcription factor |
increases response to substance |
ISO |
MYB protein results in increased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 1:15,939,771...15,973,367
Ensembl chr 1:15,939,761...15,973,057
|
|
G |
Nme7 |
NME/NM23 family member 7 |
decreases response to substance |
ISO |
NME7 protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr13:76,657,303...76,786,768
Ensembl chr13:76,657,367...76,786,765
|
|
G |
Osmr |
oncostatin M receptor |
decreases response to substance |
ISO |
OSMR protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 2:55,907,119...55,961,373
Ensembl chr 2:55,907,132...55,961,262
|
|
G |
Pkd2 |
polycystin 2, transient receptor potential cation channel |
decreases response to substance |
ISO |
PKD2 protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr14:5,237,135...5,280,455
Ensembl chr14:5,237,135...5,280,825
|
|
G |
Pkp2 |
plakophilin 2 |
increases response to substance |
ISO |
PKP2 protein results in increased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr11:84,661,783...84,727,730
Ensembl chr11:84,661,783...84,727,730
|
|
G |
Plce1 |
phospholipase C, epsilon 1 |
increases response to substance |
ISO |
PLCE1 protein results in increased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 1:236,243,445...236,552,571
Ensembl chr 1:236,244,683...236,551,438
|
|
G |
Plod2 |
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
decreases response to substance |
ISO |
PLOD2 protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 8:93,084,548...93,167,255
Ensembl chr 8:93,084,513...93,167,255
|
|
G |
Prkacb |
protein kinase cAMP-activated catalytic subunit beta |
decreases response to substance |
ISO |
PRKACB protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 2:235,636,878...235,726,928
Ensembl chr 2:235,636,885...235,726,198
|
|
G |
Ptpn13 |
protein tyrosine phosphatase, non-receptor type 13 |
decreases response to substance |
ISO |
PTPN13 protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr14:6,108,202...6,282,619
Ensembl chr14:6,108,211...6,282,563
|
|
G |
Pygb |
glycogen phosphorylase B |
increases response to substance |
ISO |
PYGB protein results in increased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 3:139,611,724...139,658,521
Ensembl chr 3:139,611,749...139,663,553
|
|
G |
Rab40b |
Rab40b, member RAS oncogene family |
increases response to substance |
ISO |
RAB40B protein results in increased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr10:106,631,514...106,659,090
Ensembl chr10:106,631,514...106,659,090
|
|
G |
Rpa1 |
replication protein A1 |
decreases response to substance |
ISO |
RPA1 protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr10:60,148,869...60,199,970
Ensembl chr10:60,148,793...60,199,949
|
|
G |
Rras2 |
RAS related 2 |
decreases response to substance |
ISO |
RRAS2 protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 1:168,233,693...168,303,111
Ensembl chr 1:168,233,693...168,303,111
|
|
G |
Sinhcaf |
SIN3-HDAC complex associated factor |
increases response to substance |
ISO |
SINHCAF protein results in increased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 4:181,888,301...181,913,294
Ensembl chr 4:181,888,312...181,910,276
|
|
G |
Stip1 |
stress-induced phosphoprotein 1 |
decreases response to substance |
ISO |
STIP1 protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 1:204,209,433...204,228,452
Ensembl chr 1:204,178,932...204,228,476
|
|
G |
Tead1 |
TEA domain transcription factor 1 |
decreases response to substance |
ISO |
TEAD1 protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 1:166,791,900...167,010,591
Ensembl chr 1:166,792,628...167,003,369
|
|
G |
Tff1 |
trefoil factor 1 |
increases response to substance |
ISO |
TFF1 protein results in increased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
|
|
G |
Thbs1 |
thrombospondin 1 |
decreases response to substance |
ISO |
THBS1 protein results in decreased susceptibility to doxifluridine |
CTD |
PMID:16734730 |
|
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
doxifluridine promotes the reaction [TNF protein results in increased expression of TYMP mRNA] 5-benzylacyclouridine inhibits the reaction [[TNF protein results in increased activity of UPP1 protein] which results in increased susceptibility to doxifluridine]; [TNF protein results in increased activity of UPP1 protein] which results in increased susceptibility to doxifluridine; [TNF protein results in increased expression of UPP1 mRNA] which results in increased susceptibility to doxifluridine |
CTD |
PMID:16397116 PMID:17988526 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tymp |
thymidine phosphorylase |
multiple interactions affects expression increases metabolic processing increases response to substance |
ISO EXP |
[5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride results in decreased activity of TYMP protein] results in decreased susceptibility to [Zidovudine co-treated with doxifluridine]; [5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride results in decreased activity of TYMP protein] which results in decreased susceptibility to doxifluridine; [IFNG protein results in increased expression of TYMP protein] which results in increased susceptibility to doxifluridine; [Paclitaxel co-treated with doxifluridine] affects the expression of TYMP mRNA; [TYMP protein results in increased expression of IFNA1 mRNA] which results in increased susceptibility to doxifluridine; [Zidovudine results in increased activity of TYMP protein] which results in increased susceptibility to doxifluridine; doxifluridine promotes the reaction [TNF protein results in increased expression of TYMP mRNA] doxifluridine affects the expression of TYMP mRNA TYMP protein results in increased metabolism of doxifluridine TYMP protein results in increased susceptibility to doxifluridine |
CTD |
PMID:15301717 PMID:15864645 PMID:16457948 PMID:17988526 PMID:18630517 PMID:21804305 More...
|
|
NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
|
|
G |
Tyms |
thymidylate synthetase |
affects expression decreases response to substance multiple interactions |
ISO |
doxifluridine affects the expression of TYMS mRNA TYMS protein results in decreased susceptibility to doxifluridine [Paclitaxel co-treated with doxifluridine] affects the expression of TYMS mRNA |
CTD |
PMID:16734730 PMID:18630517 |
|
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
|
|
G |
Upp1 |
uridine phosphorylase 1 |
multiple interactions |
ISO |
5-benzylacyclouridine inhibits the reaction [[TNF protein results in increased activity of UPP1 protein] which results in increased susceptibility to doxifluridine]; [TNF protein results in increased activity of UPP1 protein] which results in increased susceptibility to doxifluridine; [TNF protein results in increased expression of UPP1 mRNA] which results in increased susceptibility to doxifluridine |
CTD |
PMID:16397116 |
|
NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462
|
|